<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Free Radic Res. Author manuscript; available PMC 2009 5. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Free Radic Res. 2008 January ; 42(1): 20&#226;&#8364;&#8220;29. doi:10.1080/10715760701765616. <br />  <br />  <br />  <br />                            APE1/Ref-1 regulates PTEN expression mediated Egr-1 <br />  <br />                            DAMIANO FANTINI1,*, CARLO VASCOTTO1,*, MARTA DEGANUTO1, NICOLETTA BIVI1, <br />                            STEFANO GUSTINCICH2, GABRIELLA MARCON3, FRANCO QUADRIFOGLIO1, GIUSEPPE <br />                            DAMANTE1, KISHOR K. BHAKAT4, SANKAR MITRA4, GIANLUCA TELL1 <br />                            1Department Biomedical Sciences Technologies, University Udine, 33100 Udine, Italy <br />                            2Sector Neurobiology, International School Advanced Studies (SISSA), 34014 Trieste, Italy <br />                            3Department Pathology Experimental Clinical Medicine, University Udine, 33100 Udine, Italy <br />                            4Sealy Center Molecular Medicine Department Biochemistry Molecular Biology, University <br />                            Texas Medical Branch, Galveston, TX 77555, USA <br />  <br />                            Abstract <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 APE1/Ref-1, mammalian ortholog E. coli Xth, multifunctional protein possessing                                 DNA repair transcriptional regulatory activities, dual role controlling cellular response                                 oxidative stress. rate-limiting repair oxidative DNA damage including strand breaks                                 transcriptional activity modulating genes expression directly regulated Egr-1                                 p53 transcription factors. PTEN, <span id='am-13' about='obo:IMR_0001650' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-14' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="inositol phospholipid" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0001650" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>phosphoinositide</span> phosphatase, acts   switch PI-3 <br />                                 kinase/Akt signalling pathway regulates cell growth survival. shown transient <br />                                 alteration APE1 level HeLa cells modulates PTEN expression acetylatable APE1 <br />                                 required activation PTEN gene. Acetylation APE1 enhances binding distinct <br />                                 trans-acting complexes involved activation repression. acetylated protein deacetylated <br />                                 vivo histone deacetylases. exposure HeLa cells <span id='am-68' about='obo:IMR_0200487' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-69' property="oboInOwl:hasDbXref" content="KEGG:C00027" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:id" content="IMR:0200487" datatype="xsd:string"></span><span id='am-71' property="rdfs:label" content="H2O2" datatype="xsd:string"></span><span id='am-72' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>H2O2</span> histone <br />                                 deacetylase inhibitors increases acetylation APE1 induction PTEN. absence                                 induction APE1-downregulated HeLa cells confirmed APE1&apos;s role regulating inducible PTEN <br />                                 expression. APE1-dependent PTEN expression mediated Egr-1 supported                                 experiments cells ectopically expressing Egr-1.  data open new perspectives                                 comprehension functions exerted APE1 controlling cell response oxidative <br />                                 stress. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            Keywords <br />                                 APE1/Ref-1; PTEN; Egr-1; siRNA; histone acetyltransferase inhibitors; oxidative stress response <br />  <br />  <br />  <br />  <br />                            Correspondence: Gianluca Tell, Professor Molecular Biology, Department Biomedical Sciences Technologies, University                            Udine, P.le Kolbe 4, 33100 Udine, Italy. Tel: ++39 432 494311. Fax: ++39 432 494301. Email: E-mail: gtell@mail.dstb.uniud  <br />                             authors contributed equally work. <br />                            Publisher&apos;s Disclaimer: article used research, teaching private study purposes. substantial systematic <br />                            reproduction, distribution, selling, loan sub-licensing, systematic supply distribution form expressly <br />                            forbidden. <br />                            publisher does warranty express implied make representation contents complete accurate <br />                            <span id='am-12' about='oboInOwl:date' typeof='owl:Thing'>date</span>. accuracy instructions, formulae drug doses independently verified primary sources.                            publisher shall liable loss, actions, claims, proceedings, demand costs damages whatsoever howsoever caused <br />                            arising directly indirectly connection arising use material. <br />                             FANTINI et al.                                                                                               Page 2 <br />  <br />  <br />                               Introduction <br />                                             APE1/Ref-1 protein  simply indicated APE1) plays central role NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             highly regulated process cellular response oxidative stress [1,2]. activation                                             complex network cellular events determines final outcome, cell growth <br />                                             arrest, death survival cells exposed oxidative stress [1,3-6]. addition  <br />                                             characterized toxic effects, mild oxidative stress activates survival/proliferative signalling <br />                                             [7].  tight temporal control extent APE1 activation response oxidative <br />                                             stress modulate cell growth survival. <br />  <br />                                             APE1 ubiquitous multifunctional protein possessing DNA repair transcriptional <br />                                             regulatory activities. APE1 enhances DNA binding number transcription factors <br />                                             including p53, Egr-1 NF-&#206;&#186;B [1,2,8-11] acting transcriptional activator. Egr-1                                             involved regulation cell proliferation response extracellular signal                                             mitogens growth factors, oxidative stress [12,13]. Studies gene expression                                             human tumour cells tissues support Egr-1&apos;s function tumour suppressor [14,15]. Egr-1 <br />                                             regulates expression genes p53 <span id='am-6' about='obo:IMR_0001385' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-7' property="rdfs:label" content="inositol phosphate" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="phosphoinositol" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001385" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasExactSynonym" content="phosphoinositol" datatype="xsd:string"></span>phosphoinositol</span> phosphatase tensin <br />                                             homologue (PTEN) control cell-growth arrest apoptosis 16,17]. PTEN negatively <br />                                             regulates <span id='am-19' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-20' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="MPI" datatype="xsd:string"></span>phosphoinositide</span> 3-kinase/Akt signalling pathway, shown                                             involved regulation cell growth survival cell lines [18].  induction                                             PTEN activity lead inhibition cell growth ultimately apoptosis. previously <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             observed PTEN promoter regulated Egr-1 APE1-dependent manner <br />                                             [11], suggesting functional relationship proteins growth suppressive <br />                                             effects response oxidative stress. shown PTEN expression activated <br />                                             oxidative stress [19]. regulatory functions different APE1 activities                                             implemented different mechanisms:   APE1&apos;s relocalization cytoplasm                                             nucleus; (b) increase APE1&apos;s level transcriptional activation [1,5,11,20]; (c) <br />                                             APE1&apos;s post-translational modifications  acetylation phosphorylation). recently <br />                                             demonstrated [6,21], acetylation appears fine-tuning role affecting APE1&apos;s different <br />                                             activities. <br />  <br />                                             known nuclear accumulation APE1 triggers activation transcription <br />                                             factors, Egr-1 p53, functional role acetylation barely understood. <br />                                             Acetylation histones regulatory proteins commonly catalysed histone <br />                                             acetyltransferase (HAT) p300/CBP reversed histone deacetylases (HDACs), <br />                                             control acetylation level transcription factors activators [22-24].                                             observed balance acetyltransferase activity p300/CBP                                             deacetylase activity HDAC1 maintains APE1&apos;s acetylation Lys residues 6 7 (K6, K7) <br />                                             response Ca2+ levels, controlling expression target genes [6]. Inhibition HDACs <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             HDACs inhibitors causes proteins hyperacetylation [25]. correlation established <br />                                             hyperacetylated histones transcriptionally active chromatin [26,27].  <br />                                             recent studies indicate potential role HDACs inhibitors promoting differentiation                                             tumour cells, suggesting possible use anticancer agents [28,29]. <br />  <br />                                             purpose present study investigate relationship APE1,                                             acetylated form PTEN expression. observed direct correlation levels                                             APE1 PTEN suggesting functional link. Furthermore, PTEN upregulated                                             treatment H2O2 HDACs inhibitors concomitant enhanced acetylation APE1. <br />                                             APE1-mediated PTEN activation appears involve transcription factor Egr-1. <br />                                             Collectively, studies unravelled novel, indirect, regulatory function                                             APE1 PTEN activation, opening new perspectives comprehension                                             functions exerted multifunctional protein. <br />  <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                            Page 3 <br />  <br />  <br />                               Materials methods <br />                               Chemicals <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Trichostatin (TSA), sodium butyrate (NaBut) chemicals purchased                                             Sigma (Milan, Italy), unless specified. HeLa cells purchased ATCC                                             HCT116 isogenic cell lines expressing p53 (p53+/+) non-expressing p53 (p53-/-) gifts <br />                                             B. Vogelstein (Johns Hopkins University, Baltimore, MD). p53 gene inactivated <br />                                             HCT116 p53-/- cells homologous recombination. Briefly, promoterless targeting <br />                                             vectors containing geneticin hygromycin resistance gene place genomic p53 <br />                                             sequences sequentially transfected HCT116 p53+/+ cells disrupt p53 alleles <br />                                             [30]. phenotype cell line stable determined periodically Western blot <br />                                             analysis. <br />  <br />                               Cell culture analysis <br />                                             HeLa cells grown Dulbecco&apos;s Modified Eagle&apos;s Medium High Glucose (DMEMHG) <br />                                             supplemented 10% (v/v) foetal bovine serum (FBS), 2 mM <span id='am-44' about='obo:IMR_0200448' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-45' property="oboInOwl:hasDbXref" content="KEGG:C00064" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="L-Glutamine" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:id" content="IMR:0200448" datatype="xsd:string"></span>L-glutamine</span> 1% penicillin- <br />                                             streptomycin (100,000 Units/L penicillin 100 mg/L streptomycin) 37&#194;&#176;C 5% <span id='am-39' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-40' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span>CO2</span>                                             95% <span id='am-73' about='obo:IMR_0200217' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-74' property="oboInOwl:hasDbXref" content="KEGG:C00007" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="O2" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-77' property="oboInOwl:id" content="IMR:0200217" datatype="xsd:string"></span>O2</span>. HCT116p53+/+ HCT116p53-/- human colon carcinoma isogenic cell lines                                             cultured McCoy&apos;s 5A medium supplemented 10% FBS penicillin/streptomycin,                                             previously reported [6]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Cellular extracts typically prepared lysing 3 &#195;&#8212; 105 cells 50 &#206;&#188;L lysis buffer <br />                                             containing 50 mM Tris-HCl, (pH 7.5), 150 mM NaCl, 1% w/v Triton X-100, 1 mM EDTA, 0.5 <br />                                             mM PMSF, 0.1 mM DTT, 1 mM NaVO3, 1 mM NaF, protease inhibitor cocktail (Sigma),                                             analysed protein content [31] stored aliquots -80&#194;&#176;C. <br />  <br />                               Western blot analysis <br />                                             Cell extracts analysed SDS-PAGE (10% polyacrylamide) [20] separated <br />                                             proteins transferred nitrocellulose membranes (Schleicher <span id='am-32' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-33' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span>amp</span>; Schuell). pre-incubating <br />                                             5% non-fat dry milk PBS/0.1% w/v Tween-20 1 h, membranes incubated <br />                                             anti-APE1 monoclonal antibody [20] 3 h room temperature polyclonal <br />                                             anti-PTEN antibody (Santa Cruz Biotechnology , Santa Cruz, CA) overnight 4&#194;&#176;C.                                             acetylated APE1 (AcAPE1) determined using anti-acetylated APE1 <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>peptide</span>- <br />                                             specific polyclonal antibody, previously described [32]. incubation, membranes <br />                                             washed times PBS/0.1% w/v Tween-20 incubated appropriate <br />                                             secondary antibodies coupled horseradish peroxidase (Sigma) 1 h room temperature <br />                                             followed washes PBS Tween-20 0.1% w/v. end, blots developed <br />                                             using ECL chemiluminescence procedure (Amersham Pharmacia Biotech, Milan, Italy) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             quantified using Gel Doc 2000 videodensitometer (Bio-Rad, Hercules, CA, USA). APE1, <br />                                             AcAPE1 PTEN signals normalized actin quantitated blot                                             polyclonal anti-actin antibody (Sigma). <br />  <br />                               Transfection studies <br />                                             HCT116 cells (0.3 &#195;&#8212; 106 cells/100 mm dish) cotransfected using Lipofectamine 2000 <br />                                             (Invitrogen, Milan, Italy) according manufacturer&apos;s protocol various luciferase <br />                                             reporter plasmids. &#206;&#178;-galactosidase expression plasmid (CMV-&#206;&#178;-Gal) used internal <br />                                             control normalizing transfection efficiency (Roche Diagnostic, Milan, Italy). Luciferase <br />                                             (Luc) activity measured using chemiluminescence procedure [11] normalized                                             &#206;&#178;-galactosidase activity. cases, promoter activity &#206;&#178;-galactosidase <br />                                             expression plasmid affected, luciferase activity normalized total protein <br />                                             extract. studies PTEN promoter constructs, used 0.5 &#206;&#188;g plasmid <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                               Page 4 <br />  <br />  <br />                                             containing 2 kb (-1 -1978 bp) human PTEN promoter (PTEN-Luc) cloned                                             pGL3B-P10, 5&#226;&#8364;&#178; Luc gene, described earlier [16]. pcDNA5.1-APE1-c-FLAG <br />                                             plasmid, encoding C-terminal FLAG-tagged APE1 used express APE1; NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             control used pcDNA5.1 vector. Egr-1-expressing plasmid pRSV-Egr-1                                             described earlier [33]. <br />  <br />                               Transient inducible expression APE1 siRNA <br />                                             oligonucleotides used siRNA APE1 using Mittal&apos;s empirical rule [34] (sense, 5&#226;&#8364;&#178;- <br />                                             CCTGCCA CACTCAAGATCTGC-3&#226;&#8364;&#178;; antisense, 5&#226;&#8364;&#178;-GCAGAT CTTGAGTGTGGCAGG-3&#226;&#8364;&#178;) <br />                                             designed bind APE1&apos;s 21 nt mRNA segment 175 nt downstream initiation codon. <br />                                             sequences cloned BglII HindIII restriction sites pSUPER identity <br />                                             resulting plasmid pSUPER/Ref-1 confirmed direct sequencing. HeLa cells                                             transfected pSUPER/Ref-1 presence lipofectamine  48 h later, cells                                             processed analysis. <br />  <br />                                             inducible regulation APE1 expression, siRNA sequences cloned <br />                                             pTER vector [35] tetracycline- (doxycycline-) responsive promoter generate                                             pTER/Ref-1 plasmid. HeLa cells transfected pcDNA6/TR, linearized Bst1107I <br />                                             (Fermentas, St.Leon Rot, UK) incubated blasticidin (Invitrogen) 14 days                                             select resistant cells. isolating individual clones using cloning cylinders (Sigma),                                             clones expanded 107 cells. TR5 clone high level expression Tet- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             repressor transfected pTER/Ref-1 pre-digested Bst1107I (Fermentas)                                             selected resistance zeocine 14-21 days&apos; culture (Invitrogen). Thirty clones                                             grown 107 cells, control, pTER-transfected cells. induce APE1 siRNA <br />                                             cells, 1 &#206;&#188;/mL doxycycline (Sigma) added medium cells grown <br />                                             10 days analysed APE1 expression. <br />  <br />                               Statistical analysis <br />                                             Results expressed mean&#194;&#177;SD. data point represents average                                             measurements, performed independent cell preparations. Statistical <br />                                             significance means&#194;&#177;SD analysed Student&apos;s t-test way analysis                                             variance (ANOVA) differences considered significant p&lt;0.05. <br />  <br />                               Results <br />                               APE1-dependent regulation PTEN expression <br />                                             previously shown cotransfection experiments PTEN promoter activity                                             significantly enhanced HeLa cells expression APE1 [11], suggesting NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             PTEN gene regulated APE1. order confirm direct correlation APE1 <br />                                             level PTEN expression, examined effect regulation endogenous APE1 <br />                                             PTEN gene. APE1-specific small interfering RNA (siRNA), expressed plasmid, <br />                                             used reduce level endogenous APE1. HeLa cells transiently transfected                                             control siRNA APE1 specific siRNA-expressing plasmid (pSUPER/Ref-1)                                             expression levels APE1 PTEN measured Western analysis 48 h                                             transfection. Expression APE1 siRNA resulted significant decrease (~80%)                                             APE1 level, compared control cells transfection plasmid (Figure <br />                                             1A, left). time, PTEN level reduced 50% APE1 knocked                                             cells. <br />  <br />                                             confirm PTEN regulatory target ~APE1, expressed FLAG-tagged APE1 <br />                                             HeLa cells. PTEN level significantly increased APE1 expressing cells <br />                                             relative control (Figure 1A, right). <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                             Page 5 <br />  <br />  <br />                                             APE1&apos;s regulatory activity fine-tuned various mechanisms including post- <br />                                             translational modification, redox regulation target trans-acting factor nucleo- <br />                                             cytoplasmic trafficking protein itself [1,2]. recently demonstrated NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             acetylation APE1 specific Lys residues  e. K6/K7) constitutes fundamental <br />                                             mechanism modulate regulation Ca2+-dependent promoters containing negative <br />                                             Ca2+ responsive elements (nCaRE) [6].  tested acetylatable K6/K7 <br />                                             residues APE1 involved PTEN expression. analysed activation PTEN promoter- <br />                                             driven luciferase expression mediated wild type APE1 non-acetylatable R6/ <br />                                             R7 mutant [6]. Figure 1B (left panel) shows expression wild type APE1 <br />                                             protein increased activity PTEN promoter ~2-fold, expression R6/R7 mutant <br />                                             caused marginal activation conditions comparable ectopic expression wild type vs <br />                                             mutant APE1. expected, transient expression non-acetylatable APE1 protein <br />                                             unable promote endogenous PTEN expression (Figure 1B, right panel). data <br />                                             suggest acetylated lysine residues APE1 involved APE1-mediated PTEN <br />                                             expression. <br />  <br />                               PTEN activation APE1 acetylation induced H2O2 <br />                                             Expression PTEN, early regulator cellular growth suppression, enhanced thyroid <br />                                             cells oxidative stress [19].  tested H2O2 treatment similarly induce <br />                                             PTEN HeLa cells. 1 h serum starvation, HeLa cells treated various times                                             50 &#206;&#188;M H2O2. shown Figure 2A, H2O2 treatment increased endogenous PTEN protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             level time-dependent manner. <br />  <br />                                              tested possibility oxidative stress stimulates acetylation APE1                                             turn activates PTEN promoter. quantitate acetylated APE1                                             using polyclonal antibody selectively recognizes AcAPE1. antibody raised <br />                                             peptide containing acetylated Lys residues corresponding position 6 APE1.                                             polyclonal rabbit antibody does recognize 50-fold excess unmodified APE1 (data <br />                                             shown). Figure 2B shows H2O2 treatment significantly increased level AcAPE1, <br />                                             occurred early (30 min) treatment. Estimation total APE1, using                                             monoclonal antibody [20], indicated level significantly affected H2O2                                             conditions. <br />  <br />                               Elevated level acetylated APE1 PTEN upregulation HDACs inhibition <br />                                             recently demonstrated APE1 acetylation mediated p300/CBP histone <br />                                             acetyltransferase HDACs inhibition moderately enhanced level AcAPE1                                             HCT116 cells [6].  tested HDACs inhibition affect AcAPE1 levels <br />                                             HeLa cells. treated HeLa cells HDACs inhibitors,  NaBut TSA. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             longer time-frame used respect previous experiment Figure                                             chosen basis activation PTEN induction HDACs inhibitors (data shown). <br />                                             Figure 3A shows tors significantly increased APE1, albeit different <br />                                             extent, total APE1. increase levels TSA treatment                                             visible time points (data shown). <br />  <br />                                              tested HDACs inhibitors gulate PTEN expression. HeLa cells                                             HDACs inhibitors 30 h level quantitated Western blotting. Figure shows <br />                                             NaBut TSA increased PTEN protein level. <br />  <br />                               HDACs inhibitor-induced PTEN upregulation requires APE1 expression <br />                                             causal involvement APE1 upregulation PTEN expression tested                                             using HeLa cells expression endogenous APE1 conditionally knocked- <br />                                             stable transfection inducible APE1-specific siRNA expression [35]. 10 <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                             Page 6 <br />  <br />  <br />                                             days&apos; treatment doxycycline, APE1 expression reached undetectable level                                             HeLa cells expressing APE1 specific siRNA; control cells, transfected siRNA <br />                                             vector (Control) unaffected (Figure 4A, inset). test effect HDACs <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             inhibition PTEN gene expression, measured luciferase activity control 2- <br />                                             kb PTEN promoter [16]. Figure 4A shows TSA treatment caused ~5-fold increase Luc <br />                                             activity control cells NaBut increased activity ~11-fold relative untreated <br />                                             cells. APE1 siRNA-expressing cells, TSA treatment caused 2-fold NaBut                                             3.5-fold increase PTEN promoter activity. <br />  <br />                                             results, showing silencing APE1 prevents activation PTEN promoter caused <br />                                             HDACs inhibition, support major role acetylated APE1 transcriptional activation                                             PTEN gene. <br />  <br />                                             tested HDACs inhibition causes upregulation endogenous PTEN <br />                                             protein mediation APE1. measured PTEN protein levels control APE1 <br />                                             knock cells treatment NaBut TSA (Figure 4B). evident PTEN <br />                                             levels increased time-dependent fashion HDAC inhibited response <br />                                             completely blocked APE1 knock cells (Figure 4B). Taken  data <br />                                             unequivocally demonstrate essential role APE1 PTEN expression. <br />  <br />                                             unexpected observation HeLa APE1 knocked cells present higher basal level <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             PTEN protein explained complex transcriptional mechanisms controlling <br />                                             PTEN expression, involve transcription factors p53 [36], CBF-1 <br />                                             [37], NF-&#206;&#186;B [38] PPAR&#206;&#179; [39], excluding possible role protein stabilization.  <br />                                             data clearly point role APE1 controlling inducible constitutive PTEN <br />                                             expression. <br />  <br />                               APE1-mediated PTEN activation requires Egr-1 p53 <br />                                             Transcriptional activation PTEN control transcription factors,                                             p53 Egr-1 known activated APE1 [8,10,16,18,36]. p53                                             responsible basal PTEN expression, Egr-1 primarily activates PTEN expression response <br />                                             cellular stress [16]. tested involvement p53 Egr-1 APE1-mediated PTEN <br />                                             expression, using nearly isogenic pair human colon carcinoma cell line HCT116 <br />                                             expressing wild type p53. PTEN-Luc promoter contains 117 bp GC-rich sequence <br />                                             (-1031 -779 bp), minimal Egr-1 responsive element, includes Egr-1 binding <br />                                             sites [16]. promoter contains p53 response element upstream Egr-1 binding <br />                                             sites (Figure 5A). HCT116-/- HCT116+/+ cells transfected plasmids encoding <br />                                             wild type Egr-1 p53 effects PTEN promoter analysed cells <br />                                             ectopically expressing APE1 (Figure 5B). evident APE1 expression caused <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             significant (~2-fold) similar activation PTEN promoter cell lines, indicating <br />                                             stimulatory activity APE1 independent p53 status depends Egr-1. <br />                                             confirm lack involvement p53 acetylated APE1-dependent PTEN <br />                                             upregulation, effect HDACs inhibitors endogenous PTEN expression HCT116-/- <br />                                             HCT116+/+ cells examined (Figure 5C). Western blot analysis total cell extracts <br />                                             showed increase PTEN expression dependent HDACs independent                                             p53 status cell. <br />  <br />                               Discussion <br />                                             APE1 distinct functions: DNA repair transcriptional regulation [1,2].                                             essentiality APE1 cellular survival frequent expression tumour cells <br />                                             strongly suggest APE1&apos;s role preventing cell death controlling cellular proliferation <br />                                             [4,21].  ability activate transcription factors, p53 Egr-1 [10,11,40, <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                                   Page 7 <br />  <br />  <br />                                             41], mainly involved controlling cell-cycle arrest apoptosis, raises possibility <br />                                             opposite regulatory roles APE1 different cellular contexts.  APE1 act                                             transcriptional activator repressor distinct transcription factors. NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             possible different functions organized hierarchical manner. <br />  <br />                                             present study, tested PTEN, Egr-1 target gene [10,16], regulated                                             APE1 previously suggested [11]. experiments involving ectopic APE1 <br />                                             expression regulation endogenous gene indicated inducible PTEN <br />                                             expression regulated APE1. post-translational acetylation APE1 shown <br />                                             repress PTH promoter binding nCaRE [6], checked acetylation                                             APE1 control PTEN inducible activation. expression wild-type <br />                                             APE1 caused PTEN promoter activation, similar ectopic expression non-acetylatable <br />                                             R6/R7 mutant marginal effect, suggesting acetylation APE1is involved PTEN <br />                                             activation. Interestingly, oxidative stress, known induce APE1 expression, enhanced APE1 <br />                                             acetylation concomitant stimulation PTEN expression. Complementarily, treatment <br />                                             HDACs inhibitors, TSA NaBut, increased acetylation level APE1                                             enhanced PTEN expression, suggesting induction PTEN mediated APE1.                                             conclusions confirmed transfection studies PTEN expression                                             examined APE1 knocked cells. Experiments HDACs-inhibitors                                             confirmed transcriptional activation responsible PTEN expression. known <br />                                             oxidative stress promotes PTEN functional inactivation cysteine oxidation [42]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              apparent paradox induction PTEN expression oxidative stress,                                             observed HeLa thyroid cells [19] osteoblasts (data shown),                                             explained terms cellular adaptive mechanisms aiming homeostatic regulation                                             endogenous PTEN functional levels. work needed address issue. <br />  <br />                                             PTEN promoter controlled Egr-1 p53 [36].  Egr-1 <br />                                             involved primarily stress-mediated induction PTEN gene [16]. results, using <br />                                             HCT116 cell lines nearly isogenic p53, demonstrated APE1-mediated PTEN <br />                                             expression dependent trans-acting function Egr-1 p53. <br />                                             work progress, Pan et al. [43] demonstrated PTEN expression                                             induced histone deacetylase inhibitor TSA treatment Egr-1 activation. data provide <br />                                             novel molecular basis activation, suggesting upstream regulatory role                                             acetylated APE1 Egr-1 activation. precise mechanism APE1&apos;s action Egr-1-driven <br />                                             PTEN expression unknown. attempts demonstrate stable interaction                                             acetylated APE1 Egr-1 unsuccessful, similarly case observed p53 [8]. <br />                                              notion APE1 redox-regulate Egr-1 [10,11] supports existence                                             transient weak interaction factors. currently investigating role <br />                                             APE1 acetylation modulating interaction Egr-1. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             double-function APE1 gene regulation example apparent biological <br />                                             paradox. fact, number papers clearly demonstrated APE1&apos;s anti-apoptotic roles <br />                                             positive effect cell proliferation [1,2,4,21], evidence                                             potential role controlling proapoptotic functions p53-mediated activation [8,40, <br />                                             41] p21, leading cell cycle arrest inhibiting cyclin-dependent kinase [44] cyclin <br />                                             G [45]. evident anti-apoptotic roles APE1 ascribable DNA-repair <br />                                             functions [4], activities transcriptional activator (Figure 6).                                              tempting speculate function, activation transcription factors p53                                             Egr-1, ensures efficient cell-cycle arrest, act concert repair DNA damage <br />                                             protect cells accumulation oxidative damage. Obviously, proper modulation                                             interconnected functions fine-tuning needed regulating APE1 activities.  <br />                                             depth understanding processes controlling:   APE1&apos;s subcellular distribution; (ii) <br />                                             post-translational modifications; (iii) turnover (iv) recruitment diverse <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                                             Page 8 <br />  <br />  <br />                                             interacting partners response various endogenous external signals, required unravel <br />                                             complex picture. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Interestingly, dual role proteins transcriptional regulation DNA repair diverse <br />                                             pathways common phenomenon, observed cases BRCA1, ATM p53. <br />                                             regulatory proteins involved homologous recombinational repair (HR), non- <br />                                             homologous end joining (NHEJ), <span id='am-60' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-61' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-65' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-67' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> excision repair (NER), base excision repair (BER) <br />                                             mismatch repair (MMR) [46]. existence precise regulation switching <br />                                             mechanism shifting cells DNA repair mode apoptosis central avoidance                                             cancer progression, preventing clonal expansion cells unrepaired damage                                             lead mutation transformations. interesting cross-regulation, <br />                                             terms expression, does exist partners different pathways. <br />  <br />                               Acknowledgements <br />                                             financial support Telethon - Italy (grants GGP06268 GGP05062) MUR (PRIN 2005 GT FQ) <br />                                             gratefully acknowledged. SM KKB supported USPHS grants R01 CA53791 R01 ES08457.                                             authors wish thank E. Adamson (Burnham Institute, USA) PTEN promoter Egr-1 expressing plasmids <br />                                             Ms W. Smith secretarial editing assistance. <br />  <br />  <br />                               Abbreviations <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             AP-1, activator protein-1; APE1/Ref-1, Apurinic/apyrimidinic (AP) endonuclease/redox <br />                                             effector factor-1; Egr-1, Early growth response protein-1; HATs, Histone acetyltransferases; <br />                                             HDACs, Histone deacetylases; NaBut, sodium butyrate; NF-&#206;&#186;B, Nuclear Factor-&#206;&#186;B; PTEN, <br />                                             protein phosphatase tensin homologue; ROS, reactive oxygen species; TSA, trichostatin <br />                                              <br />  <br />                               References <br />                                             [1]. Tell G, Damante G, Caldwell D, Kelley MR. intracellular localization APE1/Ref-1:                                                   passive phenomenon? Antioxid Redox Signal 2005;7:367&#226;&#8364;&#8220;384. [PubMed: 15706084] <br />                                             [2]. Mitra S, Izumi T, Boldogh  Bhakat KK, Chattopadhyay R, Szczesny B. Intracellular trafficking                                                   regulation mammalian AP-endonuclease 1 (APE1), essential DNA repair protein. DNA Repair <br />                                                   (Amst) 2007;6:461&#226;&#8364;&#8220;469. [PubMed: 17166779] <br />                                             [3]. Robertson KA, Hill DP, Xu Y, Liu L, Van Epps S, Hockenbery DM, Park JR, Wilson TM, Kelley <br />                                                   MR. regulation apurinic/apyrimidinic endonuclease expression associated                                                   induction apoptosis differentiating myeloid leukemia cells. Cell Growth Differ 1997;8:443&#226;&#8364;&#8220; <br />                                                   449. [PubMed: 9101090] <br />                                             [4]. Fung H, Demple B. vital role Ape1/Ref1 protein repairing spontaneous DNA damage NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   human cells. Mol Cell 2005;17:463&#226;&#8364;&#8220;470. [PubMed: 15694346] <br />                                             [5]. Ramana CV, Boldogh  Izumi T, Mitra S. Activation apurinic/apyrimidinic endonuclease human <br />                                                   cells reactive oxygen species correlation adaptive response genotoxicity                                                   free radicals. Proc Natl Acad Sci USA 1998;95:5061&#226;&#8364;&#8220;5066. [PubMed: 9560228] <br />                                             [6]. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S. Role acetylated human AP-endonuclease <br />                                                   (APE1/Ref-1) regulation parathyroid hormone gene. EMBO J 2003;22:6299&#226;&#8364;&#8220;6309. <br />                                                   [PubMed: 14633989] <br />                                             [7]. Finkel T. Oxidant signals oxidative stress. Curr Opin Cell Biol 2003;15:247&#226;&#8364;&#8220;254. [PubMed: <br />                                                   12648682] <br />                                             [8]. Gaiddon C, Moorthy NC, Prives C. Ref-1 regulates transactivation pro-apoptotic functions <br />                                                   p53 vivo. EMBO J 1999;18:5609&#226;&#8364;&#8220;5621. [PubMed: 10523305] <br />                                             [9]. Xanthoudakis S, Curran T. Identification characterization Ref-1, nuclear protein                                                   facilitates AP-1 DNA-binding activity. EMBO J 1992;11:653&#226;&#8364;&#8220;665. [PubMed: 1537340] <br />  <br />  <br />  <br />  <br />                                                   Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                                    Page 9 <br />  <br />  <br />                                             [10]. Huang RP, Adamson ED. Characterization DNA binding properties early growth <br />                                                   response-1 (Egr-1) transcription factor: evidence modulation redox mechanism. DNA Cell <br />                                                   Biol 1993;12:265&#226;&#8364;&#8220;273. [PubMed: 8466649] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             [11]. Pines  Bivi N, Romanello M, Damante G, Kelley MR, Adamson ED, D&apos;Andrea P, Quadrifoglio <br />                                                   F, Moro L, Tell G. Cross-regulation Egr-1 APE/Ref-1 early response                                                   oxidative stress human osteoblastic HOBIT cell line: evidence autoregulatory loop. <br />                                                   Free Radic Res 2005;39:269&#226;&#8364;&#8220;281. [PubMed: 15788231] <br />                                             [12]. Huang RP, Wu JX, Fan Y, Adamson ED. UV activates growth factor receptors reactive oxygen <br />                                                   intermediates. J Cell Biol 1996;133:211&#226;&#8364;&#8220;220. [PubMed: 8601609] <br />                                             [13]. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression growth transformation                                                   induction apoptosis EGR-1. Cancer Gene Ther 1998;5:3&#226;&#8364;&#8220;28. [PubMed: 9476963] <br />                                             [14]. Huang RP, Fan Y, Belle  Niemeyer C, Gottardis MM, Mercola D, Adamson ED. Decreased <br />                                                   Egr-1 expression human, mouse rat mammary cells tissues correlates tumour <br />                                                   formation. Int J Cancer 1997;72:102&#226;&#8364;&#8220;109. [PubMed: 9212230] <br />                                             [15]. Krones-Herzig  Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson ED, Mercola <br />                                                   D. Early growth response 1 acts tumor suppressor vivo vitro regulation p53. <br />                                                   Cancer Res 2005;65:5133&#226;&#8364;&#8220;5143. [PubMed: 15958557] <br />                                             [16]. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, Belle  Egr-1 <br />                                                   transcription factor directly activates PTEN irradiation-induced signalling. Nat Cell Biol <br />                                                   2001;3:1124&#226;&#8364;&#8220;1128. [PubMed: 11781575] <br />                                             [17]. Baron V, Adamson ED, Calogero  Ragona G, Mercola D. transcription factor Egr1 direct <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   regulator multiple tumor suppressors including TGFbeta1, PTEN, p53, fibronectin. Cancer <br />                                                   Gene Ther 2006;13:115&#226;&#8364;&#8220;124. [PubMed: 16138117] <br />                                             [18]. Sansal  Sellers WR. biology clinical relevance PTEN tumor suppressor pathway. <br />                                                   J Clin Oncol 2004;22:2954&#226;&#8364;&#8220;2963. [PubMed: 15254063] <br />                                             [19]. Tell G, Pines  Arturi F, Cesaratto L, Adamson E, Puppin C, Presta  Russo D, Filetti S, Damante <br />                                                   G. Control phosphatase tensin homolog (PTEN) gene expression normal neoplastic <br />                                                   thyroid cells. Endocrinology 2004;145:4660&#226;&#8364;&#8220;4666. [PubMed: 15231710] <br />                                             [20]. Pines  Perrone L, Bivi N, Romanello M, Damante G, Gulisano M, Kelley MR, Quadrifoglio F, <br />                                                   Tell G. Activation APE1/Ref-1 dependent reactive oxygen species generated                                                   purinergic receptor stimulation <span id='am-49' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-50' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-55' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span>ATP</span>. Nucleic Acids Res 2005;33:4379&#226;&#8364;&#8220;4394. [PubMed: <br />                                                   16077024] <br />                                             [21]. Izumi T, Brown DB, Naidu CV, Bhakat KK, Macinnes MA, Saito H, Chen DJ, Mitra S.                                                   essential distinct functions mammalian abasic endonuclease. Proc Natl Acad Sci USA <br />                                                   2005;102:5739&#226;&#8364;&#8220;5743. [PubMed: 15824325] <br />                                             [22]. Grunstein M. Histone acetylation chromatin structure transcription. Nature 1997;389:349&#226;&#8364;&#8220; <br />                                                   352. [PubMed: 9311776] <br />                                             [23]. Kuo MH, Allis CD. Roles histone acetyltransferases deacetylases gene regulation. <br />                                                   Bioessays 1998;20:615&#226;&#8364;&#8220;626. [PubMed: 9780836] <br />                                             [24]. Katan-Khaykovich Y, Struhl K. Dynamics global histone acetylation deacetylation vivo: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   rapid restoration normal histone acetylation status removal activators repressors. <br />                                                   Genes Dev 2002;16:743&#226;&#8364;&#8220;752. [PubMed: 11914279] <br />                                             [25]. Davie JR. Inhibition histone deacetylase activity butyrate. J Nutr 2003;133:2485S&#226;&#8364;&#8220;2493S. <br />                                                   [PubMed: 12840228] <br />                                             [26]. Eberharter  Becker PB. Histone acetylation: switch repressive permissive <br />                                                   chromatin. Second review series chromatin dynamics. EMBO Rep 2002;3:224&#226;&#8364;&#8220;229. <br />                                                   [PubMed: 11882541] <br />                                             [27]. Davis PK, Brackmann RK. Chromatin remodeling cancer. Cancer Biol Ther 2003;2:22&#226;&#8364;&#8220;29. <br />                                                   [PubMed: 12673113] <br />                                             [28]. Lehrmann H, Pritchard LL, Harel-Bellan  Histone acetyltransferases deacetylases                                                   control cell proliferation differentiation. Adv Cancer Res 2002;86:41&#226;&#8364;&#8220;65. [PubMed: <br />                                                   12374280] <br />                                             [29]. Kim DH, Kim M, Kwon HJ. Histone deacetylase carcinogenesis inhibitors anti-cancer <br />                                                   agents. J Biochem Mol Biol 2003;36:110&#226;&#8364;&#8220;119. [PubMed: 12542981] <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                                  Page 10 <br />  <br />  <br />                                             [30]. Bunz F, Dutriaux  Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, <br />                                                   Vogelstein B. Requirement p53 p21 sustain G2 arrest DNA damage. Science <br />                                                   1998;282:1497&#226;&#8364;&#8220;1501. [PubMed: 9822382] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             [31]. Bradford MM. rapid sensitive method quantitation microgram quantities protein <br />                                                   utilizing principle protein-dye binding. Anal Biochem 1976;72:248&#226;&#8364;&#8220;254. [PubMed: 942051] <br />                                             [32]. Szczesny B, Bhakat KK, Mitra S, Boldogh  Age-dependent modulation DNA repair enzymes <br />                                                   covalent modification subcellular distribution. Mech Ageing Dev 2004;125:755&#226;&#8364;&#8220;765. <br />                                                   [PubMed: 15541770] <br />                                             [33]. Huang RP, Darland T, Okamura D, Mercola D, Adamson ED. Suppression v-sis-dependent <br />                                                   transformation transcription factor Egr-1. Oncogene 1994;9:1367&#226;&#8364;&#8220;1377. [PubMed: 8152797] <br />                                             [34]. Mittal V. Improving efficiency RNA interference mammals. Nat Rev Genet 2004;5:355&#226;&#8364;&#8220; <br />                                                   365. [PubMed: 15143318] <br />                                             [35]. van Wetering M, Oving  Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, <br />                                                   Brummelkamp TR, Agami R, Clevers H. Specific inhibition gene expression using stably <br />                                                   integrated, inducible small-interfering-RNA vector. EMBO Rep 2003;4:609&#226;&#8364;&#8220;615. [PubMed: <br />                                                   12776180] <br />                                             [36]. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW. Regulation <br />                                                   PTEN transcription p53. Mol Cell 2001;8:317&#226;&#8364;&#8220;325. [PubMed: 11545734] <br />                                             [37]. Whelan JT, Forbes SL, Bertrand FE. CBF-1 (RBP-Jkappa) binds PTEN promoter                                                   regulates PTEN gene expression. Cell Cycle 2007;6:80&#226;&#8364;&#8220;84. [PubMed: 17245125] <br />                                             [38]. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM. regulation tumor <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   suppressor PTEN tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing <br />                                                   kinase/NF-kappaB pathway linked default IkappaB-alpha autoregulatory loop. J Biol Chem <br />                                                   2004;279:4285&#226;&#8364;&#8220;4291. [PubMed: 14623898] <br />                                             [39]. Patel L, Pass  Coxon P, Downes CP, Smith SA, Macphee CH. Tumor suppressor anti- <br />                                                   inflammatory actions PPARgamma agonists mediated upregulation PTEN. Curr Biol <br />                                                   2001;11:764&#226;&#8364;&#8220;768. [PubMed: 11378386] <br />                                             [40]. Seo YR, Kelley MR, Smith ML. Selenomethionine regulation p53 ref1-dependent redox <br />                                                   mechanism. Proc Natl Acad Sci USA 2002;99:14548&#226;&#8364;&#8220;14553. [PubMed: 12357032] <br />                                             [41]. Hanson S, Kim E, Deppert W. Redox factor 1 (Ref-1) enhances specific DNA binding p53                                                   promoting p53 tetramerization. Oncogene 2005;24:1641&#226;&#8364;&#8220;1647. [PubMed: 15674341] <br />                                             [42]. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray  Downes CP. Redox regulation PI 3- <br />                                                   kinase signalling inactivation PTEN. EMBO J 2003;22:5501&#226;&#8364;&#8220;5510. [PubMed: 14532122] <br />                                             [43]. Pan L, Lu J, Wang X, Han L, Zhang Y, Han S, Huang B. Histone deacetylase inhibitor trichostatin <br />                                                   potentiates doxorubicin-induced apoptosis regulating PTEN expression. Cancer <br />                                                   2007;109:1676&#226;&#8364;&#8220;1688. [PubMed: 17330857] <br />                                             [44]. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell <br />                                                   cycle arrest compromised p21 deficiency. Nature 1995;377:552&#226;&#8364;&#8220;557. [PubMed: 7566157] <br />                                             [45]. Okamoto K, Prives C. role cyclin G process apoptosis. Oncogene 1999;18:4606&#226;&#8364;&#8220; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   4615. [PubMed: 10467405] <br />                                             [46]. Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair/pro-apoptotic dual-role proteins                                                   major DNA repair pathways: fail-safe protection carcinogenesis. Mutat Res <br />                                                   2002;511:145&#226;&#8364;&#8220;178. [PubMed: 12052432] <br />  <br />  <br />  <br />  <br />                                                  Free Radic Res. Author manuscript; available PMC 2009 5. <br />                             FANTINI et al.                                                                                         Page 11 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 1. <br />                                             APE1-dependent regulation PTEN expression.   Left) regulation PTEN                                             siRNA-mediated transient reduction APE1 expression. HeLa cells transfected 1.5 <br />                                             &#206;&#188;g pSUPER (Ctrl) pSUPER/Ref-1 plasmid; 48 h later, cell lysates (15 &#206;&#188;g)                                             used Western analysis. (Right) Upregulation endogenous PTEN transient  <br />                                             expression APE1/Ref-1. HeLa cells transfected 0.4 &#206;&#188;g pcDNA5.1                                             pcDNA5.1-APE1-c-FLAG  48 h later, cell extracts (10 &#206;&#188;g) analysed  (B, <br />                                             Left) Effect APE1 expression PTEN promoter activity. HeLa cells harvested <br />                                             cotr <br /> </body></html>